-
Je něco špatně v tomto záznamu ?
The American journal of cardiology
- Publikováno
-
New York : Cahners Publishing Company, 1958-
New York : Elsevier
Jazyk angličtina Země Spojené státy americké
Typ dokumentu periodika
NLK
ProQuest Central
od 2012-08-15 do Před 2 měsíci
Medline Complete (EBSCOhost)
od 2012-09-01 do 2015-07-15
Nursing & Allied Health Database (ProQuest)
od 2012-08-15 do Před 2 měsíci
Health & Medicine (ProQuest)
od 2012-08-15 do Před 2 měsíci
ScienceDirect (archiv)
od 1993-01-01 do 2009-12-31
IKEM
www.sciencedirect.com
ScienceDirect 1995-
Knihovny.cz ISSN
0002-9149
1879-1913
domovská stránka časopisu
- MeSH
- kardiologie MeSH
- Publikační typ
- periodika MeSH
- Konspekt
- Patologie. Klinická medicína
- NLK Obory
- kardiologie
- angiologie
Am J Cardiol
A Symposium: Adjunctive Therapies in Thrombolysis.
SuplementA Symposium: Position of Beta Blockers in Present and Future Therapy of Systemic Hypertension.
SuplementA symposium: proceedings of the second International Heart Failure Workshop.
SuplementA Symposium: Advances in Nuclear Cardiovascular Imaging.
SuplementThe hypertriglyceridemias : risk and management.
SuplementA Symposium: Thrombosis and Thrombolysis in Unstable Angina.
SuplementA Symposium: Mechanisms of Myocardial Ischemia and Injury in Unstable Angina Pectoris.
SuplementA Symposium: Ventricular Remodeling and Unloading Following Myocardial Infarction.
SuplementA Symposium: Strategies for Evaluating Thrombolytic Therapy.
SuplementA Symposium: Safety of Thrombolytic Agents.
SuplementA Symposium: Bepridil : impact on the management of angina pectoris.
Suplement SuplementA Symposium: The Ischemic Myocardium : strategies for preservation and protection.
SuplementA Symposium: The Role of Calcium Antagonists in Hypertension.
SuplementA Symposium: Beyond the Balloon : complex angioplasty for the practitioner.
Suplement SuplementA Symposium: Advances in Echocardiography : a view toward the year 2000.
SuplementA Symposium: Third North American Conference on Nitroglycerin Therapy.
SuplementA Symposium: Heart Failure Management in the 1990s : the role of lisinopril.
SuplementA Symposium: Cardioprotection : building a consensus for the 1990s.
Suplement SuplementA Symposium: Cardiac Imaging and Patient Management.
SuplementA Symposium: Coronary Artery Disease : mechanisms for myocardial protection.
SuplementOptimizing antianginal therapy : a consensus conference.
SuplementA Symposium: Triglycerides as a Vascular Risk Factor : a global forum.
SuplementSecond-generation calcium antagonism in cardiovascular disease.
Suplement Suplement Suplement SuplementA Symposium: Antioxidants and Lipid Metabolism.
SuplementBeta-adrenergic blockade in the management of chronic heart failure.
SuplementA Symposium: Aldosterone and Antialdosterone Therapy in Cardiovascular Disease.
Suplement Suplement SuplementSotalol in life-threatening ventricular arrhythmias : a unique class III antiarrhythmic.
SuplementQTc interval prolongation : Is it beneficial or harmful?.
SuplementTherapeutic advances : managing the ischemic myocardium.
SuplementIdentification and management of heterozygous familial hypercholesterolemia.
SuplementSymposium on Directional Atherectomy.
SuplementA Symposium: Controlling Cardiac Arrhythmias by Lengthening Repolarization : emerging perspectives.
SuplementA Symposium: Unresolved Issues in Thrombolysis.
SuplementA Symposium: ACE Portfolio Speakers' Conference.
Suplement SuplementA Symposium: Use of Flecainide for the Treatment of Supraventicular Arrhythmias.
Suplement SuplementAtherothrombosis : meeting held on January 28-29, 1994 in Palm Beach, Florida.
Suplement Suplement Suplement Suplement Suplement Suplement SuplementA Symposium: Arrhythmia Therapy : controversies,directions and challenges.
SuplementA Symposium: Medical Management of Silent Ischemia and Myocardial Infarction.
SuplementA Symposium: Hypertension into the Nineties.
SuplementA Symposium: Rilmenidine : a novel alpha2 agonist antihypertensive agent.
SuplementA Symposium: Advances in Clinical Practice of Nitrate Therapy.
SuplementA Symposium: Silent Myocardial Ischemia and Infarction - Past, Present and Future.
SuplementA Symposium: Interventional Cardiology - 1987.
SuplementA Symposium: The Salt-Sensitive Hypertensive Patient.
SuplementA Symposium: Advances in Congestive Heart Failure.
Suplement SuplementInternational Symposium on Supraventricular Arrhythmias : focus on flecainide.
SuplementA Symposium: Regional Blood Flow in Congestive Heart Failure.
SuplementAdvances in cardiovascular technologies : AJC guide to equipment and supplies.
SuplementA Symposium: Calcium, the Cardiovascular System and the Kidney.
SuplementA Symposium: Clinical Evaluation of Response to Antiarrhythmic Therapy.
Suplement SuplementA Symposium: Recent Approaches in Evaluation and Management of Ventricular Arrhythmias.
SuplementA Symposium: HMG CoA Reductase Inhibitors : a new therapeutic class.
SuplementA Symposium: Congestive Heart Failure : advances in treatment.
SuplementA Symposium: Magnesium Deficiency : pathogenesis, prevalence, and strategies for repletion.
SuplementA Symposium: Myocardial Infarction - direction for the '90s.
Suplement Suplement SuplementA Symposium: Thrombosis and Antithrombotic Therapy - : direction for the '90s.
Suplement SuplementA Symposium: Hormone-Electrolyte Interactions in Congestive Heart Failure.
SuplementA Symposium: Evolving Issues in the Treatment of Hypercholesterolemia.
SuplementA Symposium: Arterial Hypertension : cardiac hypertrophy and failure.
SuplementA Symposium: Indapamide and Antihypertensive Strategy.
SuplementA Symposium: The Renin-Angiotensin System : tissue specific issues.
SuplementA Symposium: Advances in Nitrate Therapy. (Part 2).
Suplement Suplement SuplementA Symposium: HMG CoA Reductase Inhibitors : a five year clinical perspective.
SuplementA Symposium: Primary and Secondary Prevention of Cardiovascular Disease.
Suplement SuplementA Symposium: Technetium-99m Myocardial Perfusion Imaging Agents and Their Relation to Thallium-201.
SuplementA Symposium: Cardiovascular Imaging in the 1990s.
SuplementA Symposium: Triggering and Circadian Variation of Onset of Acute Cardiovascular Disease.
SuplementA Symposium: The Ischemic Myocardium : new directions in evaluation and management.
SuplementA Symposium: Atherosclerosis and Vascular Protection.
SuplementA Symposium: Acute Blood Pressure Elevation and the Brain.
SuplementA Symposium: The Goals of Antihypertensive Therapy : What really counts?.
SuplementAntihypertensive treatment and cardioprotection : indapamide, a reference diuretic : symposium.
SuplementNitrates in congestive heart failure : new mechanisms and rationale for use : symposium.
SuplementPrognosis of patients with coronary artery disease on treatment with calcium channel antagonists.
Suplement SuplementICD therapy : what has been achieved? : What will we see before the year 2000? : symposium.
SuplementCurrent concepts in the management of hypercholesterolemia with an update on fluvastatin.
SuplementAcute treatment of atrial fibrillation and flutter : ibutilide in perspective.
SuplementCalcium antagonists : class distinctions, current controversies, and future trends.
SuplementControversies in thrombolytic therapy : symposium.
Suplement Suplement SuplementThe endothelium : impact on treatment strategies for coronary artery disease.
SuplementPrevention of sudden cardiac death : the Mirowski symposium : Baltimore : April 23, 1996.
Suplement SuplementCardiovascular effects of adenosine, from receptors to bedside : symposium : Philadelphia.
Suplement Suplement Suplement SuplementNew frontiers in the management of unstable coronary artery disease : symposium : Uppsala.
Suplement SuplementNew Approaches to cardiovascular therapy : symposium : March 15, 1997 : Anaheim.
SuplementThe new approaches to coronary intervention (NACI) registry : symposium.
Suplement Suplement Suplement Suplement Suplement SuplementSupraventricular arrhythmias : update 1995 : symposium : May 6, 1995 : Boston, Massachusetts.
Suplement SuplementFourth North American conference on nitroglycerin therapy : Dallas, Texas : September 27-28, 1996.
Suplement Suplement Suplement SuplementNinth annual symposium Transcatheter cardiovascular therapeutics.
Suplement Suplement Suplement SuplementCardiac arrhythmias : current management update : symposium.
Suplement Suplement Suplement SuplementImpact of multiple risk factors on coronary artery disease : beyond total cholesterol : symposium.
Suplement Suplement Suplement Suplement Suplement SuplementCardiology and cardiac surgery : a partnership in the new millennium : a symposium.
SuplementCardiovascular data on sildenafil citrate.
Suplement SuplementSodium-hydrogen exchange inhibition : a symposium : August 24, 1998, Vienna, Austria.
Suplement Suplement Suplement Suplement SuplementConsensus recommendations for the management of chronic heart failure.
Suplement Suplement Suplement Suplement Suplement Suplement Suplement Suplement Suplement Suplement SuplementA symposium: In search of the ideal lipid-lowering agent.
Suplement SuplementNew therapeutic options in the management of claudication.
SuplementA symposium: First international meeting of the Society of Atherosclerosis Imaging.
SuplementCurrent perspectives on identifying and managing hyperlipidemia.
SuplementA symposium: The postprandial state : managing its atherogenic potential.
SuplementBlood presure and beyond : treating the cardiovascular disease complex with Perindopril.
Suplement Suplement Suplement SuplementA symposium: Coronary atherosclerosis : early detection and aggressive management strategies.
SuplementHigh-density lipoprotein and coronary artery disease : the fibrate renaissance.
SuplementA Symposium: Hormone Replacement Therapy and the Pathophysiology of Cardiovascular Disease.
Suplement SuplementA Symposium: Current Concepts in Lipoprotein-Modulated Disease.
SuplementA Symposium: Focus Group on Contrast Echocardiography.
SuplementA Symposium: Combination Therapy for Dyslipidemia.
SuplementA Symposium: Society of Atherosclerosis Imaging - second international meeting.
Suplement SuplementA Symposium: Documenting Regression of Atherosclerosis: Practical Approaches in Drug Development.
Suplement SuplementA Symposium: Cardiovascular Considertaions for the Postmenopausal Woman.
Suplement Suplement SuplementA Symposium: Role of Nitrates in Congestive Heart Failure.
SuplementA Symposium: Current Issues in Antianginal Therapy.
SuplementBeta blockers and exercise : a symposium.
SuplementSymposium on Bepridil : a new antianginal agent.
SuplementSymposium on Early Intervention in Acute Myocardial Infarction : May 22, 1984, Washington, D.C.
SuplementRecent advances in antiarrhythmic therapy : Symposium on Propafenone.
Suplement SuplementSymposium on lorcainide : a new antiarrhythmic agent.
SuplementSymposium on the Management of Ventricular Dysrhythmias.
SuplementA Symposium: Lipids and Hypertension in the Elderly.
SuplementA Symposium: Management of Ventricular Arrhythmias in Patients with Congestive Heart Failure.
SuplementA Symposium: Current Trends in Diuretic Therapy.
SuplementA Symposium: Laboratory Lipid Values.
SuplementA Symposium: Transdermal Nitroglycerin : maximizing therapeutic efficacy.
SuplementA Symposium: Role of Calcium Entry-Blocking Drugs in Hypertension.
SuplementMIAMI: metoprolol in acute myocardial infarction.
SuplementA Symposium: Esmolol : an ultrashort-acting intravenous beta blocker.
SuplementA Symposium: Experimental and Clinical Aspects of Coronary Vasoconstriction.
SuplementA Symposium: Potassium, Catecholamines and Beta Blockade.
SuplementA Symposium: Cost Containment Issues in Cardiology.
SuplementA Symposium: Cardiovascular Disease in the Elderly - Etiology, Prevention, Diagnosis and Treatment.
SuplementA Symposium: Myocardial Ischemia : current status and future directions.
SuplementA Symposium: The Role of Phosphodiesterase III Inhibitors in Contemporary Cardiovascular Medicine.
SuplementA Symposium: Antihypertension Therapy in the 90s : the role of balanced hemodynamics.
SuplementA Symposium: A New Treatment for Angina Pectoris and Heart Failure.
SuplementA Symposium: New Trends in the Treatment of Rhythm Disorders.
Suplement Suplement SuplementA Symposium: Lipid Dynamics and Atherosclerosis.
SuplementA Symposium: Cardiovascular Therapy : the next step.
SuplementA Symposium: Cardiovascular Diagnosis : implications for imaging in the 1990s.
SuplementA Symposium: Pharmacologic and Therapeutic Aspects of Urapidil.
SuplementA Symposium: The George E. Burch Festschrift.
Suplement SuplementA Symposium: The Use of Encainide in Supraventricular Tachycardias.
SuplementA Symposium: Intraventional Cardiology at a Crossroad : diagnostics and therapeutics.
SuplementA Symposium: Bevantolol : a new cardiovascular agent with a unique profile.
SuplementA Symposium: Future Directions in Calcium Channel Blockade with Focus on Systemic Hypertension.
Suplement Suplement SuplementA Symposium: Hypertension, Diuretics and Diuretic-Induced Hypokalemia.
SuplementA Symposium: New Developments in the Treatment of Hypercholesterolemia - Probucol.
SuplementA Symposium: New Directions in Treatment of Patients at Risk of Coronary Artery Disease.
SuplementA Symposium: Clinical Applications of Nonselective Beta Blockers.
SuplementA Symposium: Guanfacine : a new choice in centrally acting antihypertensive agents.
SuplementA Symposium: Calcium Antagonists in Hypertension : focus on verapamil.
SuplementA Symposium: Nicardipine : a vasoselective calcium antagonist.
SuplementA Symposium: Pirmenol : a unique, new antiarrhythmic agent.
SuplementA Symposium: Doxazosin : coronary artery disease risk factor management.
SuplementA Symposium: Beta-Blockade, Cardioselectivity and Intrinsic Sympathomimetic Activity.
SuplementA Symposium: Perspectives on Proarrhythmia.
SuplementA Symposium: Ramipril : a new angiotensin converting enzyme inhibitor.
SuplementA Symposium: The Concept of the Total Ischemic Burden.
SuplementA Symposium: Calcium Antagonists : emerging clinical opportunities.
Suplement SuplementThe Göteborg metoprolol trial in acute myocardial infarction.
Suplement SuplementSymposium on Flecainide Acetate.
SuplementProceedings of a Symposium First-line Therapy for Hypertension : changing directions.
SuplementSymposium on Perspectives on the Treatment of Vetricular Arrhythmias.
SuplementSymposium on the Role of Oxprenolol (TRASICOR) in Systemic Hypertension.
Suplement Suplement SuplementProceedings of a Symposium: Initial Therapy in Hypertension.
SuplementA Symposium: Cardioprotection in Ischemic Heart Disease : Fact or fantasy?.
SuplementA Symposium: Restenosis After Percutaneous Transluminal Coronary Angioplasty.
SuplementA Symposium: The Use of Enoximone in Heart Failure.
SuplementA Symposium: Use of Beta Blockers as Antiarrhythmic Agents.
SuplementA Symposium: Hypertension : the preventable cardiovascular risk factor.
SuplementA Symposium: Ethmozine (Moricizine HCI) : a new antiarrhthmic agent.
SuplementA Symposium: New Approaches to Cardiovascular Therapy.
SuplementA Symposium: Nitroglycerin Therapy : a contemporary perspective.
SuplementA Symposium: Hypertension : the heart and kidney.
SuplementA Symposium: Behavioral Disorders in Heart Disease.
SuplementA Symposium: Biology of Atherosclerosis and Its Implications for Treatment Strategies.
SuplementStatins and the vascular wall : clinical and mechanistic correlates of early benefit.
SuplementA Symposium: Rosuvastatin : an efficacy assessment based on pooled trial data.
Suplement SuplementA Symposium: Resynchronizing the Rhythm in Congestive Heart Failure.
SuplementA Symposium: Update on High-Density Lipoprotein Cholesterol : insights from an expert roundtable.
SuplementA Symposium: From Prevention to management of Chronic Heart Failure.
Suplement SuplementIntegration of vascular biology into understanding coronary artery disease and risk reduction.
SuplementA Symposium: Effective Strategies for the Management of Coronary Disease.
Suplement SuplementA Symposium: Charting the Universe in Dyslipidemia Management.
SuplementA Symposium: Erectile Dysfunction and Cardiovascular Risk Factors.
SuplementAngiogenic gene therapy : a novel treatment paradigm for coronary artery disease.
Suplement Suplement Suplement Suplement Suplement Suplement
2x měsíčně
(1991-)
32x ročně
19x ročně
Následný nakladatel: Elsevier, New York
Citace a odkazy3.603 (2007); 3.015 (2006); 3.059 (2005); 3.140 (2004); 3.059 (2003); 2.327 (2002); 2.637 (2001); 2.762 (2000); 2.361 (1999); 2.137 (1998); 2.402 (1997)
Vlastník | Detaily | Služby |
---|---|---|
NLK |
NLK
1958-2010
Print 1958-99,2000-09
Signatura
406, 406 ; B 901, B 901
[668]
Rok 1958 neúplný; chybí č.4/83, č.5/84 |
viz E-zdroje |
IKEM |
IKEM
1960-2012
Print 1960-99,2000-11
Online 1995-
[250]
el. přístup v konsorciu ScienceDirect |
viz E-zdroje |
Další knihovny | Detaily | Služby |
ABA001 | ABA001 1976-1984 | |
ABC094 | ABC094 1983-1986 | |
ABE206 |
ABE206
1990, 1996-2008
r.1990 neúplný |
|
BAA006 | BAA006 1976-2000 | |
BAB029 | BAB029 1984-1992 | |
BAD003 | BAD003 1966, 1972-2015 | |
BAE206 | BAE206 1984-1988, 1992 | |
BAE207 | BAE207 1988-1990 | |
BAE220 | BAE220 1990-1994, 2002 | |
BBE201 | BBE201 1987-1993 | |
BJE202 | BJE202 1991-1994, 1996-1999 | |
BOD002 | BOD002 1965-1990 | |
CLE201 | CLE201 1989-2002 | |
HKD001 |
HKD001
1976-
r.78-79,82-83,86,88-89,91,97 neúpl. |
|
JHE201 | JHE201 1991-2000 | |
KED002 |
KED002
1978-1993, 1995-2012
neúplné ročníky |
|
MTE201 | MTE201 1993, 1996-2000 | |
OLA001 | OLA001 1976-1985 | |
OLD012 |
OLD012
1991-2008
Online časopis - MVS dle licenčních podmínek |
|
OSA001 | OSA001 1957-1981 | |
OSE201 |
OSE201
1992-2012
neúpl. |
|
PND001 | PND001 1976-1980, 1983-1997 | |
POE201 | POE201 1998-1999 | |
PXE201 | PXE201 1991 | |
SKE201 | SKE201 1991-1992 | |
TVE201 | TVE201 1996-1997 | |
KZ a.s. ULE201 |
KZ a.s.
1979-1981, 1995-2012
2012/109/1-5 |
|
ZIE201 | ZIE201 1991-1992 | |
ZLE201 |
ZLE201
1992-1996
neúplné ročníky |
|
ZVE201 |
ZVE201
1991-1992
neúpl.roky |
- 000
- 05409nas 22008891a 4500
- 001
- MED00000236
- 003
- CZ-PrNML
- 005
- 20201214084353.0
- 008
- 980407c19589999xxu p eng||
- 009
- SE
- 022 __
- $a 0002-9149
- 022 __
- $a 1879-1913 (online)
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu $c US
- 072 _7
- $x Patologie. Klinická medicína $a 616 $2 Konspekt $7 sk136316
- 080 __
- $a 612.17 $2 h
- 080 __
- $a 616-005 $2 h
- 080 __
- $a 616.13 $2 h
- 080 __
- $a 616.12 $2 h
- 210 1_
- $a Am J Cardiol $2 MEDLINE
- 222 _4
- $a The American journal of cardiology $q r
- 245 04
- $a The American journal of cardiology
- 260 __
- $a New York : $b Cahners Publishing Company, $c 1958-
- 260 3_
- $a New York : $b Elsevier
- 300 __
- $a sv.
- 310 __
- $a 2x měsíčně $b 1991-
- 321 __
- $a 32x ročně
- 321 __
- $a 19x ročně
- 362 0_
- $a Vol. 1, no. 1 (Jan.1958)-
- 500 __
- $a Následný nakladatel: Elsevier, New York
- 510 4_
- $a 3.603 (2007); 3.015 (2006); 3.059 (2005); 3.140 (2004); 3.059 (2003); 2.327 (2002); 2.637 (2001); 2.762 (2000); 2.361 (1999); 2.137 (1998); 2.402 (1997)
- 650 07
- $a kardiologie $2 mednas $7 nlk20040147870
- 650 07
- $a kardiologie $2 czmesh $7 D002309
- 650 07
- $a angiologie $2 mednas $7 nlk20040148017
- 655 _7
- $a periodika $2 czmesh $7 D020492
- 710 2_
- $a American College of Cardiology $7 nlk20030131403
- 770 0_
- $w MED00015208 $t Symposium Adjunctive Therapies in Thrombolysis
- 770 0_
- $w MED00015209 $t Symposium Position of Beta Blockers in Present and Future Therapy of Systemic Hypertension
- 770 0_
- $w MED00015210 $t symposium proceedings of the second International Heart Failure Workshop
- 770 0_
- $w MED00015211 $t Symposium Advances in Nuclear Cardiovascular Imaging
- 770 0_
- $w MED00015212 $t The hypertriglyceridemias
- 770 0_
- $w MED00015213 $t Symposium Thrombosis and Thrombolysis in Unstable Angina
- 770 0_
- $w MED00015214 $t Symposium Mechanisms of Myocardial Ischemia and Injury in Unstable Angina Pectoris
- 770 0_
- $w MED00015215 $t Symposium Ventricular Remodeling and Unloading Following Myocardial Infarction
- 770 0_
- $w MED00015216 $t Symposium Strategies for Evaluating Thrombolytic Therapy
- 770 0_
- $w MED00016539 $t Symposium Safety of Thrombolytic Agents
- 770 0_
- $w MED00016540 $t Symposium Bepridil
- 770 0_
- $w MED00016541 $t Symposium Hypertension Management Strategies for the 1990s
- 770 0_
- $w MED00016542 $t Symposium The Ischemic Myocardium
- 770 0_
- $w MED00016543 $t Symposium The Role of Calcium Antagonists in Hypertension
- 770 0_
- $w MED00016544 $t Symposium Beyond the Balloon
- 770 0_
- $w MED00016545 $t Symposium Management of Heart Failure in the 1990s
- 770 0_
- $w MED00016546 $t Symposium Advances in Echocardiography
- 770 0_
- $w MED00016784 $t Symposium Third North American Conference on Nitroglycerin Therapy
- 770 0_
- $w MED00016785 $t Symposium Heart Failure Management in the 1990s
- 770 0_
- $w MED00016786 $t Symposium Cardioprotection
- 770 0_
- $w MED00016787 $t Symposium Systemic Hypertension
- 770 0_
- $w MED00016788 $t Symposium Cardiac Imaging and Patient Management
- 770 0_
- $w MED00016789 $t Symposium Coronary Artery Disease
- 770 0_
- $w MED00016790 $t Optimizing antianginal therapy
- 770 0_
- $w MED00016791 $t Symposium Triglycerides as a Vascular Risk Factor
- 770 0_
- $w MED00018172 $t Second-generation calcium antagonism in cardiovascular disease
- 770 0_
- $w MED00018174 $t Myocardial ischemia
- 770 0_
- $w MED00018175 $t Evidence that ACE inhibitors are cardioprotective increases
- 770 0_
- $w MED00018176 $t Hydroxymethylglutaryl coenzyme A reductase inhibition
- 770 0_
- $w MED00018972 $t Symposium Antioxidants and Lipid Metabolism
- 770 0_
- $w MED00018973 $t Beta-adrenergic blockade in the management of chronic heart failure
- 770 0_
- $w MED00018974 $t Symposium Aldosterone and Antialdosterone Therapy in Cardiovascular Disease
- 770 0_
- $w MED00018975 $t Symposium The Clinical Applications of the Intracoronary Doppler Guidewire Flow Velocity in Patients
- 770 0_
- $w MED00018976 $t Recent advances in angiotensin-converting enzyme inhibition in the treatment of hypertension and heart failure
- 770 0_
- $w MED00018977 $t Sotalol in life-threatening ventricular arrhythmias
- 770 0_
- $w MED00018978 $t QTc interval prolongation
- 770 0_
- $w MED00018979 $t Therapeutic advances
- 770 0_
- $w MED00018980 $t Identification and management of heterozygous familial hypercholesterolemia
- 770 0_
- $w MED00018981 $t Symposium on Directional Atherectomy
- 770 0_
- $w MED00018982 $t Symposium Controlling Cardiac Arrhythmias by Lengthening Repolarization
- 770 0_
- $w MED00018983 $t Symposium Unresolved Issues in Thrombolysis
- 770 0_
- $w MED00018984 $t Symposium ACE Portfolio Speakers Conference
- 770 0_
- $w MED00019046 $t Imidazoline receptors
- 770 0_
- $w MED00020020 $t Symposium Use of Flecainide for the Treatment of Supraventicular Arrhythmias
- 770 0_
- $w MED00021557 $t Prostacyclin
- 770 0_
- $w MED00021558 $t Atherothrombosis
- 770 0_
- $w MED00021559 $t Multivessel PTCA versus CABG
- 770 0_
- $w MED00021560 $t The evolving role of cardiac imaging in the assesment of coronary artery disease
- 770 0_
- $w MED00021561 $t Left ventricular dysfunction, calcium antagonism, and nisoldipine
- 770 0_
- $w MED00021562 $t From mitochondrial metabolism to coronary artery disease
- 770 0_
- $w MED00021563 $t Progress in hypertensive heart disease
- 770 0_
- $w MED00021564 $t From hypertension to heart failure
- 770 0_
- $w MED00029814 $t Symposium Arrhythmia Therapy
- 770 0_
- $w MED00029815 $t Symposium Medical Management of Silent Ischemia and Myocardial Infarction
- 770 0_
- $w MED00029816 $t Symposium Hypertension into the Nineties
- 770 0_
- $w MED00029817 $t Symposium Rilmenidine
- 770 0_
- $w MED00029818 $t Symposium Advances in Clinical Practice of Nitrate Therapy
- 770 0_
- $w MED00029819 $t Symposium Silent Myocardial Ischemia and Infarction Past Present and Future
- 770 0_
- $w MED00029820 $t Symposium Interventional Cardiology 1987
- 770 0_
- $w MED00029821 $t Symposium The Salt Sensitive Hypertensive Patient
- 770 0_
- $w MED00029822 $t Symposium Advances in Congestive Heart Failure
- 770 0_
- $w MED00029823 $t Symposium Focus on Heart Failure
- 770 0_
- $w MED00029824 $t International Symposium on Supraventricular Arrhythmias
- 770 0_
- $w MED00029825 $t Symposium Regional Blood Flow in Congestive Heart Failure
- 770 0_
- $w MED00029826 $t Advances in cardiovascular technologies
- 770 0_
- $w MED00029827 $t Symposium Calcium the Cardiovascular System and the Kidney
- 770 0_
- $w MED00029828 $t Symposium Clinical Evaluation of Response to Antiarrhythmic Therapy
- 770 0_
- $w MED00029829 $t Symposium Second International Conference on Hypercholesterolemia
- 770 0_
- $w MED00029830 $t Symposium Recent Approaches in Evaluation and Management of Ventricular Arrhythmias
- 770 0_
- $w MED00029831 $t Symposium HMG CoA Reductase Inhibitors
- 770 0_
- $w MED00032473 $t Symposium Congestive Heart Failure
- 770 0_
- $w MED00032474 $t Symposium Magnesium Deficiency
- 770 0_
- $w MED00032475 $t Symposium Myocardial Infarction direction for the 90s
- 770 0_
- $w MED00032476 $t Symposium Controlling Cardiac Arrhythmias with Sotalol a Broad Spectrum Antiarrhythmic with Beta Blocking Effects and Class III Activity
- 770 0_
- $w MED00032477 $t Symposium The Cardiac Arrhythmia Suppression Trial
- 770 0_
- $w MED00032478 $t Symposium Thrombosis and Antithrombotic Therapy
- 770 0_
- $w MED00032479 $t Symposium Pharmacologic Management of Ventricular Arrhythmias
- 770 0_
- $w MED00032480 $t Symposium Hormone Electrolyte Interactions in Congestive Heart Failure
- 770 0_
- $w MED00032481 $t Symposium Evolving Issues in the Treatment of Hypercholesterolemia
- 770 0_
- $w MED00032482 $t Symposium Arterial Hypertension
- 770 0_
- $w MED00032483 $t Symposium Indapamide and Antihypertensive Strategy
- 770 0_
- $w MED00033233 $t Symposium The Renin Angiotensin System
- 770 0_
- $w MED00033234 $t Symposium Advances in Nitrate Therapy
- 770 0_
- $w MED00033235 $t Symposium international update the important role of aldosterone and aldosterone antagonism in cardiovascular medicine
- 770 0_
- $w MED00033236 $t Symposium The Significance of High Density Lipoprotein Cholesterol in the Prevention of Coronary Artery Disease
- 770 0_
- $w MED00033237 $t Symposium HMG CoA Reductase Inhibitors
- 770 0_
- $w MED00033238 $t Symposium Primary and Secondary Prevention of Cardiovascular Disease
- 770 0_
- $w MED00033239 $t Symposium Angiotensin Converting Enzyme Inhibition Therapy in the Treatment of Congestive Heart Failure
- 770 0_
- $w MED00033240 $t Symposium Technetium 99m Myocardial Perfusion Imaging Agents and Their Relation to Thallium 201
- 770 0_
- $w MED00033241 $t Symposium Cardiovascular Imaging in the 1990s
- 770 0_
- $w MED00033242 $t Symposium Triggering and Circadian Variation of Onset of Acute Cardiovascular Disease
- 770 0_
- $w MED00033243 $t Symposium The Ischemic Myocardium
- 770 0_
- $w MED00033244 $t Symposium Atherosclerosis and Vascular Protection
- 770 0_
- $w MED00033870 $t Symposium Acute Blood Pressure Elevation and the Brain
- 770 0_
- $w MED00033871 $t Symposium The Goals of Antihypertensive Therapy
- 770 0_
- $w MED00035158 $t Antihypertensive treatment and cardioprotection
- 770 0_
- $w MED00035159 $t Nitrates in congestive heart failure
- 770 0_
- $w MED00035160 $t Prognosis of patients with coronary artery disease on treatment with calcium channel antagonists
- 770 0_
- $w MED00035161 $t Transcatheter Cardiovascular Therapeutics Symposium : abstracts $d New York : Excerpta Medica, [1996?]-
- 770 0_
- $w MED00035162 $t ICD therapy
- 770 0_
- $w MED00035163 $t Current concepts in the management of hypercholesterolemia with an update on fluvastatin
- 770 0_
- $w MED00035164 $t Acute treatment of atrial fibrillation and flutter
- 770 0_
- $w MED00035165 $t Calcium antagonists
- 770 0_
- $w MED00035166 $t Controversies in thrombolytic therapy
- 770 0_
- $w MED00035473 $t Targeted prevention for the higher-risk patient with hypercholesterolemia
- 770 0_
- $w MED00035474 $t Cholesterol-lowering trials
- 770 0_
- $w MED00043693 $t The endothelium
- 770 0_
- $w MED00043694 $t Prevention of sudden cardiac death
- 770 0_
- $w MED00043695 $t Calcium antagonists in hypertension
- 770 0_
- $w MED00043696 $t Cardiovascular effects of adenosine, from receptors to bedside
- 770 0_
- $w MED00043697 $t Myocardial ischemia
- 770 0_
- $w MED00043698 $t Autocrine and paracrine signaling between contracting myocardium and coronary endothelium during ischemia
- 770 0_
- $w MED00043700 $t Maximizing therapeutic outcomes in the management of acute ischemic coronary syndromes
- 770 0_
- $w MED00043703 $t New frontiers in the management of unstable coronary artery disease
- 770 0_
- $w MED00043720 $t Changing trends in antiarrhythmic therapy
- 770 0_
- $w MED00043721 $t New Approaches to cardiovascular therapy
- 770 0_
- $w MED00043722 $t The New approaches to coronary intervention (NACI) registry
- 770 0_
- $w MED00043723 $t Beta-blocker therapy for heart failure
- 770 0_
- $w MED00043724 $t Pharmacologic and clinical perspectives on mibefradil
- 770 0_
- $w MED00043725 $t Current focus in treating and managing coronary artery disease and heart failure
- 770 0_
- $w MED00043726 $t Beta blockade in cardiovascular disease
- 770 0_
- $w MED00043727 $t Stroke
- 770 0_
- $w MED00044278 $t Supraventricular arrhythmias
- 770 0_
- $w MED00044279 $t New age in the pharmacologic therapy of cardiac arrhythmias
- 770 0_
- $w MED00058173 $t Fourth North American conference on nitroglycerin therapy
- 770 0_
- $w MED00058174 $t The Role of statins in patients with hypertriglyceridemia
- 770 0_
- $w MED00058175 $t Treatment of atrial fibrillation in the era of managed care
- 770 0_
- $w MED00058176 $t Can antiarrhythmic drugs survive survival trials
- 770 0_
- $w MED00058177 $t Ninth annual symposium Transcatheter cardiovascular therapeutics
- 770 0_
- $w MED00058178 $t Guidelines for clinial evaluation, development, and regulation of lipid-acting anti-atherosclerosis agents
- 770 0_
- $w MED00058179 $t Ninth international congress on echocardiography
- 770 0_
- $w MED00058180 $t New insights into the pathogenesis and management of coronary artery disease
- 770 0_
- $w MED00058181 $t Cardiac arrhythmias
- 770 0_
- $w MED00058182 $t Metabolic management of ischemic heart disease
- 770 0_
- $w MED00058183 $t The Lipoprotein and coronary atherosclerosis study (LCAS) in context
- 770 0_
- $w MED00058185 $t Atrial fibrillation
- 770 0_
- $w MED00058186 $t Impact of multiple risk factors on coronary artery disease
- 770 0_
- $w MED00058187 $t Endothelial function and cardiovascular disease
- 770 0_
- $w MED00058188 $t New Advances in dyslipidemia
- 770 0_
- $w MED00058189 $t Low-molecular-weight heparins in arterial thrombosis
- 770 0_
- $w MED00058190 $t Anticoagulant therapy
- 770 0_
- $w MED00058191 $t Calcium antagonists and the diabetic patient
- 770 0_
- $w MED00070777 $t Cardiology and cardiac surgery
- 770 0_
- $w MED00070778 $t Cardiovascular data on sildenafil citrate
- 770 0_
- $w MED00070779 $t The role of the platelet and acute coronary syndromes
- 770 0_
- $w MED00070780 $t Sodium-hydrogen exchange inhibition
- 770 0_
- $w MED00070781 $t From increased energy metabolism to cardiac hypertrophy and failure
- 770 0_
- $w MED00070782 $t New frontiers in the electrical management of cardiac disorders
- 770 0_
- $w MED00070783 $t Clinical significance and management of hypertriglyceridemia
- 770 0_
- $w MED00070784 $t Positive inotropy by calcium sensitization
- 770 0_
- $w MED00070850 $t Consensus recommendations for the management of chronic heart failure
- 770 0_
- $w MED00081827 $t Atrial fibrillation
- 770 0_
- $w MED00081828 $t Expanding the impact of statin therapy
- 770 0_
- $w MED00081829 $t Sexual activity and cardiac risk
- 770 0_
- $w MED00081830 $t Tenth international congress on echocardiography
- 770 0_
- $w MED00081831 $t Management of the patient after percutaneous coronary intervention
- 770 0_
- $w MED00081833 $t New directions in the understanding and management of acute coronary syndromes
- 770 0_
- $w MED00081834 $t Converging electrical therapies for the heart
- 770 0_
- $w MED00081835 $t The imperative to raise low levels of high-density lipoprotein cholesterol
- 770 0_
- $w MED00081836 $t Managing acute coronary syndromes
- 770 0_
- $w MED00099292 $t symposium Utilization of surrogate markers of atherosclerosis for the clinical development of pharmaceutical agents
- 770 0_
- $w MED00099295 $t symposium In search of the ideal lipid lowering agent
- 770 0_
- $w MED00099297 $t symposium Pressure platelets and plague
- 770 0_
- $w MED00099299 $t New therapeutic options in the management of claudication
- 770 0_
- $w MED00099300 $t symposium First international meeting of the Society of Atherosclerosis Imaging
- 770 0_
- $w MED00099301 $t Current perspectives on identifying and managing hyperlipidemia
- 770 0_
- $w MED00099303 $t symposium The postprandial state
- 770 0_
- $w MED00099304 $t Blood presure and beyond
- 770 0_
- $w MED00099305 $t symposium Adressing unanswered questions in the treatment of atherosclerosis
- 770 0_
- $w MED00099306 $t symposium Interventions in cardiology
- 770 0_
- $w MED00099307 $t symposium The relevance of tissue angiotensin converting enzyme
- 770 0_
- $w MED00099308 $t symposium Coronary atherosclerosis
- 770 0_
- $w MED00099309 $t High-density lipoprotein and coronary artery disease
- 770 0_
- $w MED00115019 $t Symposium Hormone Replacement Therapy and the Pathophysiology of Cardiovascular Disease
- 770 0_
- $w MED00115020 $t Symposium Evolution of Type 2 Diabetes Mellitus Management Assessment and Clinical Application of Newer Findings
- 770 0_
- $w MED00115022 $t Symposium Current Concepts in Lipoprotein Modulated Disease
- 770 0_
- $w MED00115023 $t Symposium Focus Group on Contrast Echocardiography
- 770 0_
- $w MED00115024 $t Symposium Combination Therapy for Dyslipidemia
- 770 0_
- $w MED00115025 $t Symposium Society of Atherosclerosis Imaging second international meeting
- 770 0_
- $w MED00115026 $t Symposium New Frontiers in Cardiovascular Clinical Trials the ONTARGET Study in High risk Patients
- 770 0_
- $w MED00115027 $t Symposium Documenting Regression of Atherosclerosis Practical Approaches in Drug Development
- 770 0_
- $w MED00115028 $t Symposium National Cholesterol Education Program Adult Treatment Panel III Impact and Implementation of the New Guidelines
- 770 0_
- $w MED00115029 $t Symposium Cardiovascular Considertaions for the Postmenopausal Woman
- 770 0_
- $w MED00115030 $t Nonsteroidal anti-inflammatory drugs, coxibs, and cardio-renal physiology
- 770 0_
- $w MED00115881 $t Symposium Amrinone
- 770 0_
- $w MED00115882 $t Symposium Role of Nitrates in Congestive Heart Failure
- 770 0_
- $w MED00115883 $t Symposium Current Issues in Antianginal Therapy
- 770 0_
- $w MED00115884 $t Beta blockers and exercise
- 770 0_
- $w MED00115885 $t Symposium on Bepridil
- 770 0_
- $w MED00115886 $t Symposium on Early Intervention in Acute Myocardial Infarction
- 770 0_
- $w MED00115887 $t Recent advances in antiarrhythmic therapy
- 770 0_
- $w MED00115888 $t The decline in coronary heart disease mortality
- 770 0_
- $w MED00115889 $t Symposium on lorcainide
- 770 0_
- $w MED00115890 $t Symposium on the Management of Ventricular Dysrhythmias
- 770 0_
- $w MED00115904 $t Symposium Lipids and Hypertension in the Elderly
- 770 0_
- $w MED00115905 $t Symposium Management of Ventricular Arrhythmias in Patients with Congestive Heart Failure
- 770 0_
- $w MED00115906 $t Symposium Current Trends in Diuretic Therapy
- 770 0_
- $w MED00115908 $t Symposium Laboratory Lipid Values
- 770 0_
- $w MED00115912 $t Symposium Transdermal Nitroglycerin
- 770 0_
- $w MED00115915 $t Symposium Role of Calcium Entry Blocking Drugs in Hypertension
- 770 0_
- $w MED00115917 $t MIAMI: metoprolol in acute myocardial infarction
- 770 0_
- $w MED00115920 $t Symposium Esmolol
- 770 0_
- $w MED00115922 $t Symposium Experimental and Clinical Aspects of Coronary Vasoconstriction
- 770 0_
- $w MED00115924 $t Symposium Potassium Catecholamines and Beta Blockade
- 770 0_
- $w MED00115927 $t Symposium Cost Containment Issues in Cardiology
- 770 0_
- $w MED00115938 $t Symposium Cardiovascular Disease in the Elderly Etiology Prevention Diagnosis and Treatment
- 770 0_
- $w MED00115939 $t Symposium Myocardial Ischemia
- 770 0_
- $w MED00115940 $t Symposium The Role of Phosphodiesterase III Inhibitors in Contemporary Cardiovascular Medicine
- 770 0_
- $w MED00115941 $t Symposium Antihypertension Therapy in the 90s
- 770 0_
- $w MED00115942 $t Symposium A New Treatment for Angina Pectoris and Heart Failure
- 770 0_
- $w MED00115943 $t Symposium New Trends in the Treatment of Rhythm Disorders
- 770 0_
- $w MED00115953 $t Symposium Clinical Experience with a Second Generation Calcium Antagonist Nicardipine a Vasoselective Agent
- 770 0_
- $w MED00115956 $t Symposium Pharmacology and Therapeutic Considerations of Amlodipine a New 1 4 Dihydropyridine Calcium Antagonist
- 770 0_
- $w MED00115959 $t Symposium Lipid Dynamics and Atherosclerosis
- 770 0_
- $w MED00115961 $t Symposium Cardiovascular Therapy
- 770 0_
- $w MED00115964 $t Symposium Cardiovascular Diagnosis
- 770 0_
- $w MED00115968 $t Symposium Pharmacologic and Therapeutic Aspects of Urapidil
- 770 0_
- $w MED00115971 $t Symposium The George E Burch Festschrift
- 770 0_
- $w MED00115972 $t Symposium Early Intervention in the Treatment of Acute Myocardial Infarction
- 770 0_
- $w MED00115973 $t Symposium The Use of Encainide in Supraventricular Tachycardias
- 770 0_
- $w MED00115974 $t Symposium Intraventional Cardiology at a Crossroad
- 770 0_
- $w MED00115978 $t Symposium Bevantolol
- 770 0_
- $w MED00115979 $t Symposium Future Directions in Calcium Channel Blockade with Focus on Systemic Hypertension
- 770 0_
- $w MED00115980 $t Symposium Encainide
- 770 0_
- $w MED00115981 $t Symposium Detection Quantification and Clinical Significance of Silent Myocardial Ischemia in Coronary Artery Disease
- 770 0_
- $w MED00115982 $t Symposium Hypertension Diuretics and Diuretic Induced Hypokalemia
- 770 0_
- $w MED00115983 $t Symposium New Developments in the Treatment of Hypercholesterolemia Probucol
- 770 0_
- $w MED00115984 $t Symposium New Directions in Treatment of Patients at Risk of Coronary Artery Disease
- 770 0_
- $w MED00115985 $t Symposium Clinical Applications of Nonselective Beta Blockers
- 770 0_
- $w MED00115986 $t Symposium Guanfacine
- 770 0_
- $w MED00115987 $t Symposium Calcium Antagonists in Hypertension
- 770 0_
- $w MED00115988 $t Symposium Nicardipine
- 770 0_
- $w MED00115989 $t Symposium Pirmenol
- 770 0_
- $w MED00115990 $t Symposium Doxazosin
- 770 0_
- $w MED00115991 $t Symposium Beta Blockade Cardioselectivity and Intrinsic Sympathomimetic Activity
- 770 0_
- $w MED00115992 $t Symposium Perspectives on Proarrhythmia
- 770 0_
- $w MED00115993 $t Symposium Ramipril
- 770 0_
- $w MED00115994 $t Symposium The Concept of the Total Ischemic Burden
- 770 0_
- $w MED00115995 $t Symposium Calcium Antagonists
- 770 0_
- $w MED00115996 $t Symposium The Calcium Ion Cardiac Myocyte and Vascular Smooth Muscle in Hypertension and its Treatment
- 770 0_
- $w MED00116110 $t The Göteborg metoprolol trial in acute myocardial infarction
- 770 0_
- $w MED00116111 $t Proceedings of the National Heart, Lung, and Blood Institute Workshop on the Outcome of Percutaneous Transluminal Coronary Angioplasty
- 770 0_
- $w MED00116112 $t Symposium on Flecainide Acetate
- 770 0_
- $w MED00116114 $t Proceedings of a Symposium First-line Therapy for Hypertension
- 770 0_
- $w MED00116115 $t Symposium on Perspectives on the Treatment of Vetricular Arrhythmias
- 770 0_
- $w MED00116116 $t Symposium on the Role of Oxprenolol (TRASICOR) in Systemic Hypertension
- 770 0_
- $w MED00116117 $t Symposium on High-Density Lipoproteins and Coronary Artery Disease
- 770 0_
- $w MED00116118 $t Symposium on the Physiology and Pathology of the Coronary Circulation and Coronary Heart Disease
- 770 0_
- $w MED00116119 $t Proceedings of a Symposium: Initial Therapy in Hypertension
- 770 0_
- $w MED00116147 $t Symposium Cardioprotection in Ischemic Heart Disease
- 770 0_
- $w MED00116148 $t Symposium Restenosis After Percutaneous Transluminal Coronary Angioplasty
- 770 0_
- $w MED00116149 $t Symposium The Use of Enoximone in Heart Failure
- 770 0_
- $w MED00116150 $t Symposium Use of Beta Blockers as Antiarrhythmic Agents
- 770 0_
- $w MED00116151 $t Symposium Hypertension
- 770 0_
- $w MED00116152 $t Symposium Ethmozine Moricizine HCI
- 770 0_
- $w MED00116153 $t Symposium New Approaches to Cardiovascular Therapy
- 770 0_
- $w MED00116154 $t Symposium Nitroglycerin Therapy
- 770 0_
- $w MED00116155 $t Symposium Hypertension
- 770 0_
- $w MED00116156 $t Symposium Behavioral Disorders in Heart Disease
- 770 0_
- $w MED00118387 $t Symposium Biology of Atherosclerosis and Its Implications for Treatment Strategies
- 770 0_
- $w MED00118388 $t Statins and the vascular wall
- 770 0_
- $w MED00118389 $t Symposium Rosuvastatin
- 770 0_
- $w MED00155323 $t Angioplasty Summit ... TCT Asia Pacific... $d New York : Elsevier, [2005?]-
- 770 0_
- $w MED00118390 $t Symposium Resynchronizing the Rhythm in Congestive Heart Failure
- 770 0_
- $w MED00118391 $t Symposium Update on High Density Lipoprotein Cholesterol
- 770 0_
- $w MED00118392 $t Symposium From Prevention to management of Chronic Heart Failure
- 770 0_
- $w MED00118393 $t Symposium Managing Cardiovascular and Cerebrovascular Risk
- 770 0_
- $w MED00118395 $t Integration of vascular biology into understanding coronary artery disease and risk reduction
- 770 0_
- $w MED00118423 $t Symposium Effective Strategies for the Management of Coronary Disease
- 770 0_
- $w MED00118424 $t Symposium New Insight into Understanding the Relation of Type 2 Diabetes Mellitus Insulin Resistance and Cardiovascular Disease
- 770 0_
- $w MED00118425 $t Symposium Charting the Universe in Dyslipidemia Management
- 770 0_
- $w MED00118427 $t Symposium Erectile Dysfunction and Cardiovascular Risk Factors
- 770 0_
- $w MED00118428 $t Angiogenic gene therapy
- 770 0_
- $w MED00081832 $t Twelfth annual symposium Transcatheter cardiovascular therapeutics : October 17-22, 2000, in Washington, DC / editor in chief William C. Roberts ... [et al.] $d New York : Excerpta Medica, 2000
- 770 0_
- $w MED00099302 $t Thirteenth annual symposium transcatheter cardiovascular therapeutics : September 11-16, 2001, in Washington, DC $d New York : Excerpta Medica, 2001
- 770 0_
- $w MED00115021 $t Fourteenth Annual Symposium Transcatheter Cardiovascular Therapeutics : abstracts $d New York : Excerpta Medica, 2002
- 770 0_
- $w MED00043704 $t Ninth annual transcatheter cardiovascular therapeutics symposium : Washington / September 24-28, 1997 $d New York : Excerpta Medica, 1997
- 770 0_
- $w MED00058184 $t Tenth annual symposium Transcatheter cardiovascular therapeutics : October 7-11, 1998 in Washington / editor in chief William C. Roberts $d New York : Excerpta Medica, 1998
- 770 0_
- $w MED00118426 $t Fifteenth annual Symposium Transcatheter Cardiovascular Therapeutics : September 15-17, 2003 $d New York : Excerpta Medica, 2003
- 856 4_
- $u http://www.ajconline.org/ $y domovská stránka časopisu
- 857 4_
- $u www.elsevier.com/locate/amjcard
- 910 __
- $a ABA008 $b B 901 $c 406 $p Rok 1958 neúplný; chybí č.4/83, č.5/84 $r 1958-99,2000-09 $t p $y x
- 910 __
- $a ABC048 $l 1995- $p el. přístup v konsorciu ScienceDirect $r 1960-99,2000-11 $y 0
- 990 __
- $a 20041003 $b ABA008
- 991 __
- $a 20201214084353 $b ABA008
- 999 __
- $a kom $b medvik21 $g 189 $s 236
- BAS __
- $a SKP $a 39 $a 37
- BAS __
- $a NML $a 18 $a 02 $a 25 $a MRG
- BAS __
- $a SKP $a 39 $a 37
- ELZ __
- $a ABC048 $p ScienceDirect 1995- $u http://www.sciencedirect.com/science/journal/00029149